Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 08, 2023

BUY
$39.13 - $47.24 $8,647 - $10,440
221 Added 2.01%
11,190 $453,000
Q2 2023

Aug 14, 2023

BUY
$43.93 - $46.76 $481,868 - $512,910
10,969 New
10,969 $493,000
Q2 2022

Aug 10, 2022

SELL
$42.98 - $49.77 $13,452 - $15,578
-313 Reduced 6.13%
4,793 $225,000
Q1 2022

May 12, 2022

SELL
$42.23 - $54.3 $102,069 - $131,243
-2,417 Reduced 32.13%
5,106 $249,000
Q4 2021

Feb 10, 2022

BUY
$50.62 - $56.47 $103,062 - $114,972
2,036 Added 37.11%
7,523 $418,000
Q3 2021

Nov 12, 2021

BUY
$46.55 - $56.83 $22,809 - $27,846
490 Added 9.81%
5,487 $283,000
Q2 2021

Aug 06, 2021

SELL
$46.28 - $52.75 $6,432 - $7,332
-139 Reduced 2.71%
4,997 $242,000
Q1 2021

May 10, 2021

BUY
$46.25 - $56.02 $20,118 - $24,368
435 Added 9.25%
5,136 $250,000
Q4 2020

Feb 10, 2021

BUY
$46.09 - $54.74 $9,863 - $11,714
214 Added 4.77%
4,701 $250,000
Q3 2020

Nov 13, 2020

BUY
$42.51 - $52.42 $190,742 - $235,208
4,487 New
4,487 $234,000
Q4 2019

Feb 14, 2020

SELL
$25.41 - $43.1 $300,625 - $509,916
-11,831 Closed
0 $0
Q3 2019

Nov 12, 2019

BUY
$32.73 - $40.81 $11,357 - $14,161
347 Added 3.02%
11,831 $387,000
Q2 2019

Aug 13, 2019

SELL
$35.73 - $41.39 $798,744 - $925,273
-22,355 Reduced 66.06%
11,484 $466,000
Q1 2019

May 15, 2019

BUY
$33.78 - $40.68 $850,141 - $1.02 Million
25,167 Added 290.21%
33,839 $1.38 Million
Q4 2018

Feb 14, 2019

SELL
$32.65 - $37.95 $60,565 - $70,397
-1,855 Reduced 17.62%
8,672 $298,000
Q3 2018

Nov 09, 2018

BUY
$35.99 - $39.39 $145,939 - $159,726
4,055 Added 62.65%
10,527 $400,000
Q2 2018

Aug 14, 2018

BUY
$31.23 - $37.47 $202,120 - $242,505
6,472 New
6,472 $233,000

Others Institutions Holding QGEN

About QIAGEN N.V.


  • Ticker QGEN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 227,694,000
  • Market Cap $10.5B
  • Description
  • QIAGEN N.V. offers sample to insight solutions that transform biological materials into molecular insights worldwide. The company provides primary sample technology consumables, such as nucleic stabilization and purification kits for primary sample materials, manual and automated processing for genotyping, gene expression, and viral and bacteria...
More about QGEN
Track This Portfolio

Track High Tower Advisors, LLC Portfolio

Follow High Tower Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of High Tower Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on High Tower Advisors, LLC with notifications on news.